Anifrolumab (Saphnelo) listed in MB

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.

For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Lupus Blog Articles:

Lupus Fatigue and Exercise: Practical Movement Strategies

Read

Invisible Disability and Lupus: When Disability Isn’t Visible | Lupus Canada

Read

Oral Ulcers and Lupus: More Than a Mouth Sore | Lupus Canada

Read